Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Aren’t Crazy About Lam Research Corporation (NASDAQ:LRCX) Anymore

Lam Research Corporation (NASDAQ:LRCX) was in 20 hedge funds’ portfolio at the end of December. LRCX shareholders have witnessed a decrease in enthusiasm from smart money recently. There were 23 hedge funds in our database with LRCX holdings at the end of the previous quarter.

To the average investor, there are tons of methods shareholders can use to monitor publicly traded companies. A duo of the best are hedge fund and insider trading activity. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the elite investment managers can trounce their index-focused peers by a significant amount (see just how much).

Lam Research Corporation (NASDAQ:LRCX)Equally as important, positive insider trading activity is another way to break down the world of equities. As the old adage goes: there are plenty of stimuli for an insider to cut shares of his or her company, but just one, very obvious reason why they would buy. Several academic studies have demonstrated the useful potential of this tactic if piggybackers understand what to do (learn more here).

With these “truths” under our belt, it’s important to take a look at the recent action regarding Lam Research Corporation (NASDAQ:LRCX).

What does the smart money think about Lam Research Corporation (NASDAQ:LRCX)?

At year’s end, a total of 20 of the hedge funds we track were bullish in this stock, a change of -13% from the third quarter. With the smart money’s sentiment swirling, there exists an “upper tier” of notable hedge fund managers who were boosting their stakes substantially.

Of the funds we track, Eric Bannasch’s Cadian Capital had the largest position in Lam Research Corporation (NASDAQ:LRCX), worth close to $47 million, comprising 1.5% of its total 13F portfolio. On Cadian Capital’s heels is Royce & Associates, managed by Chuck Royce, which held a $45 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Some other hedge funds that hold long positions include Jim Simons’s Renaissance Technologies, Christopher Lord’s Criterion Capital and D. E. Shaw’s D E Shaw.

Due to the fact that Lam Research Corporation (NASDAQ:LRCX) has experienced falling interest from the smart money, it’s safe to say that there lies a certain “tier” of funds who were dropping their positions entirely last quarter. At the top of the heap, David Tepper’s Appaloosa Management LP dumped the largest stake of the “upper crust” of funds we track, comprising close to $27 million in stock.. John Overdeck and David Siegel’s fund, Two Sigma Advisors, also cut its stock, about $8 million worth. These transactions are interesting, as aggregate hedge fund interest fell by 3 funds last quarter.

How have insiders been trading Lam Research Corporation (NASDAQ:LRCX)?

Insider trading activity, especially when it’s bullish, is most useful when the company in focus has seen transactions within the past half-year. Over the last half-year time frame, Lam Research Corporation (NASDAQ:LRCX) has seen zero unique insiders purchasing, and 1 insider sales (see the details of insider trades here).

With the returns demonstrated by our strategies, everyday investors should always keep an eye on hedge fund and insider trading sentiment, and Lam Research Corporation (NASDAQ:LRCX) applies perfectly to this mantra.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!